300009 安科生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)13.30017.98524.39523.4617.350
总资产报酬率 ROA (%)10.77514.01818.40317.7465.761
投入资产回报率 ROIC (%)13.01517.52223.68522.8647.233

边际利润分析
销售毛利率 (%)75.97377.39478.35378.40680.062
营业利润率 (%)33.09431.79732.24236.12113.715
息税前利润/营业总收入 (%)33.20531.59931.96835.66813.281
净利润/营业总收入 (%)28.66728.22729.96031.6459.378

收益指标分析
经营活动净收益/利润总额(%)95.05894.034101.66692.447207.494
价值变动净收益/利润总额(%)2.0103.232-0.5604.9298.622
营业外收支净额/利润总额(%)-0.126-0.421-0.440-0.977-0.786

偿债能力分析
流动比率 (X)3.7813.4082.7452.8273.066
速动比率 (X)3.3252.9632.4682.5162.777
资产负债率 (%)14.81516.26820.57120.08920.864
带息债务/全部投入资本 (%)-1.629-1.573-1.701-2.329-2.970
股东权益/带息债务 (%)-6,022.573-6,203.621-5,718.036-4,160.325-3,302.521
股东权益/负债合计 (%)551.703493.686366.977375.201364.013
利息保障倍数 (X)217.080-488.601-240.501-347.433-40.631

营运能力分析
应收账款周转天数 (天)60.04370.44859.99464.78269.678
存货周转天数 (天)164.298167.191129.323140.078140.021